2,2,3,3,3-pentafluoro-1-(1H-imidazol-2-yl)propan-1-one | 2302096-53-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 2,2,3,3,3-pentafluoro-1-(1H-imidazol-2-yl)propan-1-one
• CAS: 2302096-53-1
• 化学式: C₆H₃F₅N₂O
• 分子量: 214.09
• InChiKey: YQWOFYKDJMRTLF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  45.8
• 氢给体数：
  1
• 氢受体数：
  7

文献信息

• Composition and processes for analysis of pharmacologic agents in biological samples
  申请人：Morrison F. Janet

  公开号：US20050037386A1

  公开（公告）日：2005-02-17

  A method for extracting and detecting analytes that are metabolically associated with biological samples, as well as, for distinguishing between those which are environmentally associated and those which are metabolically incorporated is disclosed.

  本发明公开了一种提取和检测与生物样本代谢相关的分析物的方法，以及区分环境相关分析物和代谢结合分析物的方法。
• NANOPARTICULES HYBRIDES ORGANIQUES INORGANIQUES A BASE DE CARBOXYLATES DE FER
  申请人：Centre National de la Recherche Scientifique- CNRS

  公开号：EP2193137A1

  公开（公告）日：2010-06-09
• SOLIDE HYBRIDE ORGANIQUE INORGANIQUE A SURFACE MODIFIEE
  申请人：Centre National de la Recherche Scientifique- CNRS

  公开号：EP2193136A1

  公开（公告）日：2010-06-09
• [EN] COMPOSITIONS AND PROCESSES FOR ANALYSIS OF PHARMACOLOGIC AGENTS IN BIOLOGICAL SAMPLES<br/>[FR] COMPOSITIONS ET PROCEDES D'ANALYSE D'AGENTS PHARMACOLOGIQUES DANS DES ECHANTILLONS BIOLOGIQUES
  申请人：DRUG RISK SOLUTIONS L L C

  公开号：WO2005039381A2

  公开（公告）日：2005-05-06

  A method for extracting and detecting metabolically associated analytes from biological samples using supercritical fluid extraction (SFE) and chromatography (SFC) is disclosed. Also disclosed is a method for distinguishing between those analytes that are environmentally associated from those that are metabolically incorporated.
• [EN] ORGANIC/INORGANIC HYBRID NANOPARTICULATES MADE FROM IRON CARBOXYLATES<br/>[FR] NANOPARTICULES HYBRIDES ORGANIQUES INORGANIQUES A BASE DE CARBOXYLATES DE FER
  申请人：CENTRE NAT RECH SCIENT

  公开号：WO2009077670A1

  公开（公告）日：2009-06-25

  La presentee invention se rapporte a des nanoparticules de materiau hybride metal-organique a base de carboxylates de fer, utilisables par exemple comme agent de contraste. Ces particules peuvent egalement etre utilisees pour l'eiranagasinement et Ia vectorisation de molecules d'interet telles que des principes pharmaceutiquement actifs, des composes d'interet en cosmetique et des marqueurs. Outre leurs proprietes intrinseques en imagerie, ces nanoparticules presentent de bons resultats en terme de capacites de charge en actifs medicamenteux et de biocompatibilite.